NovaBay Pharmaceuticals to Hold Third Quarter 2017 Conference Call on November 14

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing its prescription Avenova® lid and lash hygiene product for the domestic eye care market, announces that it will report third quarter 2017 financial results after market close on Tuesday, November 14. Management will hold an investment community conference call that day to discuss financial results and provide a Company update.   DATE:   Tuesday, Novem